Specific subcellular localization of siRNAs delivered by lipoplex in MCF-7 breast cancer cells
Carole Lavigne1, Alain R Thierry
1Laboratoire de biologie cellulaire et de thérapie génique, Département de Biologie, Université de Moncton, 165 Massey Avenue, Moncton, New Brunswick, E1A 3E9, Canada. lavigncar@umoncton.ca
Abstract:
In order to better understand the mechanism of delivery of siRNAs by lipid-based vectors, we investigated the subcellular distribution of siRNAs directed against cyclin D1 delivered by the DLS system in the breast cancer cell line MCF-7. Cells were treated with cyclopentenone or 17beta-estradiol to modulate the level of expression of cyclin D1 mRNA. We qualitatively observed that siRNA localized to specific cytoplasmic compartments in the periphery of the nucleus in granular-like structures that do not correspond to early endosomal vesicles. In cells treated with either cyclopentenone or 17beta-estradiol cellular distribution of siRNAs was not affected but variations in the amount of siRNAs present in cells were found. We suggest these variations might be associated with the effects of cyclopentenone and 17beta-estradiol in cyclin D1 gene expression. Low cytotoxicity and highly cellular uptake of lipoplexes was observed in the presence of serum indicating that the DLS system could be a useful tool for siRNA vectorization in vitro and in vivo.
Insights
This study tracked small interfering RNAs (siRNAs) targeting cyclin D1 in breast cancer cells using a lipid-based delivery system. The siRNAs localized to unique cytoplasmic structures, showing potential for targeted gene silencing.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Lipid-based vectors are crucial for delivering small interfering RNAs (siRNAs) for gene silencing.
- Understanding siRNA subcellular localization is key to optimizing delivery mechanisms.
- Cyclin D1 is a significant target in breast cancer therapy.
Purpose of the Study:
- To investigate the subcellular distribution of cyclin D1-targeting siRNAs delivered via a DLS lipid-based system in MCF-7 breast cancer cells.
- To examine the impact of modulating cyclin D1 mRNA expression on siRNA localization and uptake.
- To assess the efficacy and safety of the DLS system for siRNA delivery.
Main Methods:
- MCF-7 cells were treated with cyclopentenone or 17beta-estradiol to alter cyclin D1 mRNA levels.
- Subcellular distribution of siRNAs was qualitatively observed using microscopy.
- Cellular uptake and cytotoxicity of lipoplexes were evaluated in the presence of serum.
Main Results:
- siRNAs localized to distinct, granular cytoplasmic structures near the nucleus, not in early endosomes.
- Modulating cyclin D1 expression did not alter siRNA distribution but affected cellular siRNA amounts.
- The DLS system demonstrated low cytotoxicity and high cellular uptake, even with serum present.
Conclusions:
- The DLS system effectively delivers siRNAs to specific cytoplasmic compartments in breast cancer cells.
- Variations in cellular siRNA uptake may correlate with gene expression modulation.
- The DLS system shows promise as a versatile tool for in vitro and in vivo siRNA delivery.
Related Concept Videos
MicroRNAs
MicroRNAs
Regulated mRNA Transport

